Rivaroxaban Viatris (previously Rivaroxaban Mylan) Unió Europea - grec - EMA (European Medicines Agency)

rivaroxaban viatris (previously rivaroxaban mylan)

mylan ireland limited - rivaroxaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - Αντιθρομβωτικοί παράγοντες - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

ACNOGEN/GENEPHARM 10MG/CAP ΚΑΨΑΚΙΟ, ΜAΛΑΚΟ Grècia - grec - Εθνικός Οργανισμός Φαρμάκων

acnogen/genepharm 10mg/cap καψακιο, μaλακο

genepharm ae (0000000073) 18 ΧΛΜ. Λ. ΜΑΡΑΘΩΝΟΣ, ΠΑΛΛΗΝΗ ΑΤΤΙΚΗΣ, 15351 - isotretinoin - ΚΑΨΑΚΙΟ, ΜaΛΑΚΟ - 10mg/cap - 0004759482 isotretinoin 10.000000 mg - isotretinoin

ACNOGEN/GENEPHARM 20MG/CAP ΚΑΨΑΚΙΟ, ΜAΛΑΚΟ Grècia - grec - Εθνικός Οργανισμός Φαρμάκων

acnogen/genepharm 20mg/cap καψακιο, μaλακο

genepharm ae (0000000073) 18 ΧΛΜ. Λ. ΜΑΡΑΘΩΝΟΣ, ΠΑΛΛΗΝΗ ΑΤΤΙΚΗΣ, 15351 - isotretinoin - ΚΑΨΑΚΙΟ, ΜaΛΑΚΟ - 20mg/cap - 0004759482 isotretinoin 20.000000 mg - isotretinoin

ATRIDOX 44MG/PF.SYR PS.GNV.GEL Grècia - grec - Εθνικός Οργανισμός Φαρμάκων

atridox 44mg/pf.syr ps.gnv.gel

tolmar gmbh, germany - doxycycline - ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΠΑΡΑΣΚΕΥΗ ΓΕΛΗΣ ΓΙΑ ΟΥΛΑ - 44mg/pf.syr - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

ZOLANDIL GR.CAP 20MG/CAP Grècia - grec - Εθνικός Οργανισμός Φαρμάκων

zolandil gr.cap 20mg/cap

libytec ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε. Δ.Τ. libytec a.e. Λ. Βουλιαγμένης 24, 16777 Ελληνικό 210.9609960 - omeprazole - gr.cap (ΓΑΣΤΡΟΑΝΘΕΚΤΙΚΟ ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 20mg/cap - omeprazole 20mg - omeprazole

ZOLANDIL GR.CAP 40MG/CAP Grècia - grec - Εθνικός Οργανισμός Φαρμάκων

zolandil gr.cap 40mg/cap

libytec ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε. Δ.Τ. libytec a.e. Λ. Βουλιαγμένης 24, 16777 Ελληνικό 210.9609960 - omeprazole - gr.cap (ΓΑΣΤΡΟΑΝΘΕΚΤΙΚΟ ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 40mg/cap - omeprazole 40mg - omeprazole

VICKS SINEX NASPR.SOL 0,5MG/ML Grècia - grec - Εθνικός Οργανισμός Φαρμάκων

vicks sinex naspr.sol 0,5mg/ml

ΠΡΟΚΤΕΡ & ΓΚΑΜΠΛ ΕΛΛΑΣ ΜΟΝΟΠΡΟΣΩΠΗ ΕΤΑΙΡΕΙΑ ΠΕΡΙΟΡΙΣΜΕΝΗΣ ΕΥΘΥΝΗΣ Αγίου Κωνσταντίνου 49,, 151 24 Μαρούσι 210.8764000 - oxymetazoline hydrochloride - naspr.sol (ΡΙΝΙΚΟ ΕΚΝΕΦΩΜΑ, ΔΙΑΛΥΜΑ) - 0,5mg/ml - oxymetazoline hydrochloride 0,5mg - oxymetazoline